# Liver-directed Chemotherapy After Surgery of Liver Metastases of Colorectal Cancer in Patients With High Risk of Recurrence of Their Disease

> **NCT07284394** · PHASE3 · NOT_YET_RECRUITING · sponsor: **UNICANCER** · enrollment: 272 (estimated)

## Conditions studied

- Colorectal Adenocarcinoma Metastatic in the Liver
- Colorectal Cancer

## Interventions

- **DRUG:** Arterial catheter infusion chemotherapy
- **DRUG:** IV Chemotherapy (Regimen 1)

## Key facts

- **NCT ID:** NCT07284394
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2030-09
- **Final completion:** 2034-09
- **Target enrollment:** 272 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07284394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07284394, "Liver-directed Chemotherapy After Surgery of Liver Metastases of Colorectal Cancer in Patients With High Risk of Recurrence of Their Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07284394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*